This research explores salivary anticoagulant polypeptides found in haematophagous organisms. These polypeptides function by inhibiting host proteases, specifically targeting the catalytic site and a positively charged exosite. The study identifies and characterizes these molecules, highlighting their potential as therapeutic agents. Their unique mechanism of action offers a novel approach to anticoagulant therapies.